Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: Final results of a phase 2, single-blind, randomised controlled trial (COV006).

Li G. et al, (2025), Vaccine, 62

Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: results from COV-BOOST trial.

Janani L. et al, (2025), J Infect

Immunogenicity and Safety of ChAdOx1 nCoV-19 (AZD1222) as a Homologous Fourth-Dose Booster: A Substudy of the Phase 3 COV003 Trial in Brazil

Costa Clemens SA. et al, (2025), Mayo Clinic Proceedings Innovations Quality and Outcomes, 9

Nipah virus vaccines evaluated in pigs as a 'One Health' approach to protect public health.

McLean RK. et al, (2025), NPJ Vaccines, 10

Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222).

Belij-Rammerstorfer S. et al, (2025), EBioMedicine, 118

Translational science at the undergraduate level: awakening talents to overcome the valley of death - case report.

Ferreira RS. et al, (2025), J Venom Anim Toxins Incl Trop Dis, 31

Long-term respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination

Mitsi E. et al, (2023)

Include forthcoming?